Targeting of Receptor for Advanced Glycation End Products Suppresses Cyst Growth in Polycystic Kidney Disease

Dose-Dependent Effects of Sirolimus on mTOR Signaling and Polycystic Kidney Disease

(2012) Z. Novalic et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes

(2011) Ping Zhu et al.   EXPERIMENTAL DERMATOLOGY

The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood

(2011) Cosimo Giannini et al.   PEDIATRIC NEPHROLOGY

Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

(2011) V. Takiar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effects of Specific Genes Activating RAGE on Polycystic Kidney Disease

(2010) Eun Young Park et al.   AMERICAN JOURNAL OF NEPHROLOGY

Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts

(2010) S. Xia et al.   DEVELOPMENT

Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor

(2010) K. C. Sourris et al.   DIABETOLOGIA

Advanced glycation end-products and the kidney

(2010) Martin Busch et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

The cell biology of polycystic kidney disease

(2010) Hannah C. Chapin et al.   JOURNAL OF CELL BIOLOGY

Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease

(2010) Iram Zafar et al.   KIDNEY INTERNATIONAL

Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models

(2010) Thomas A Natoli et al.   NATURE MEDICINE

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

(2010) Andreas L. Serra et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease

(2010) Gerd Walz et al.   NEW ENGLAND JOURNAL OF MEDICINE

The receptor RAGE: Bridging inflammation and cancer

(2009) Astrid Riehl et al.   Cell Communication and Signaling

Advanced Glycation End-Products Induce Tubular CTGF via TGF- -Independent Smad3 Signaling

(2009) A. C.K. Chung et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

RAGE, glomerulosclerosis and proteinuria: Roles in podocytes and endothelial cells

(2009) Vivette D’Agati et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1

(2008) Sekiya Shibazaki et al.   HUMAN MOLECULAR GENETICS

Cyst Formation in Kidney via B-Raf Signaling in thePKD2Transgenic Mice

(2008) Eun Young Park et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

RAGE Mediates Podocyte Injury in Adriamycin-induced Glomerulosclerosis

(2008) J. Guo et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo

(2008) Feng Wei et al.   KIDNEY INTERNATIONAL

A tumor necrosis factor-α–mediated pathway promoting autosomal dominant polycystic kidney disease

(2008) Xiaogang Li et al.   NATURE MEDICINE